Compare POM & ETB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | POM | ETB |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Investment Bankers/Brokers/Service |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 555.4M | 448.6M |
| IPO Year | 2025 | N/A |
| Metric | POM | ETB |
|---|---|---|
| Price | $0.35 | $15.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 6.4M | 71.8K |
| Earning Date | 12-03-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.23% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $51,210,721.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.13 | N/A |
| 52 Week Low | $0.26 | $11.59 |
| 52 Week High | $6.43 | $14.08 |
| Indicator | POM | ETB |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 58.59 |
| Support Level | N/A | $14.91 |
| Resistance Level | N/A | $15.25 |
| Average True Range (ATR) | 0.00 | 0.14 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 90.91 |
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.
Eaton Vance Tax-Managed Buy-Write Income Fund is a United States-based diversified closed ended management investment company. The fund's investment objective is to provide current income and gains, with a secondary objective of capital appreciation. It invests in a diversified portfolio of common stocks and writes call options on one or more U.S. indices on a substantial portion of the value of its common stock portfolio to generate current earnings from the option premium. Its portfolio of investments consists of aerospace and defense, banks, biotechnology, chemicals, consumer finance, industrial conglomerates, and others.